Home
>
National Drug Code (NDC)
>
Prevnar
Prevnar - 0005-1970-50 - (Pneumococcal 7-valent)
Drug Information of Prevnar
| Product NDC: | 0005-1970 |
| Proprietary Name: | Prevnar |
| Non Proprietary Name: | Pneumococcal 7-valent |
| Active Ingredient(s): | 2; 2; 2; 2; 2; 4; 2 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL & nbsp; Pneumococcal 7-valent |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Prevnar
| Product NDC: | 0005-1970 |
| Labeler Name: | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103905 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20000301 |
Package Information of Prevnar
| Package NDC: | 0005-1970-50 |
| Package Description: | 10 SYRINGE in 1 CARTON (0005-1970-50) > .5 mL in 1 SYRINGE (0005-1970-49) |
NDC Information of Prevnar
| NDC Code | 0005-1970-50 |
| Proprietary Name | Prevnar |
| Package Description | 10 SYRINGE in 1 CARTON (0005-1970-50) > .5 mL in 1 SYRINGE (0005-1970-49) |
| Product NDC | 0005-1970 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Pneumococcal 7-valent |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20000301 |
| Marketing Category Name | BLA |
| Labeler Name | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
| Substance Name | STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGA |
| Strength Number | 2; 2; 2; 2; 2; 4; 2 |
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| Pharmaceutical Classes | Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [Chemical/Ingredient],Vaccines, Conjugate [Chemical/Ingredient],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pneumococcal Vaccines [Chemical/Ingredient] |
